Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,948,723
+$8,455,848 QoQ
Shares Held
138,613
+18.2% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#85
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Creative Planning holds $1,825,978,859 across 16 Drug Manufacturers - General names. BIIB ranks #12 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
445,706 | $534,593,191 | |
| 2 | JNJ |
Johnson & Johnson
|
1,384,963 | $351,739,052 | |
| 3 | ABBV |
AbbVie Inc.
|
1,126,243 | $283,407,788 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,354,765 | $174,087,302 | |
| 5 | AMGN |
Amgen Inc
|
258,171 | $93,488,882 | |
| 6 | NVS |
Novartis AG
|
546,659 | $85,672,398 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
414,367 | $52,351,126 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
887,032 | $51,110,783 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,948,723 | 138,613 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $21,492,875 | 117,236 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $15,839,451 | 90,002 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,607,105 | 68,583 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,958,564 | 55,407 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,636,112 | 26,572 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,753,574 | 24,546 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,669,951 | 13,774 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $4,236,271 | 18,274 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $2,975,909 | 13,801 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $3,235,401 | 12,503 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,410,521 | 13,270 | Shares | Defined | 2023-11-16 | |
| 2023-06-30 | $4,236,857 | 14,874 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $3,784,822 | 13,613 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,739,804 | 13,505 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,100,404 | 11,612 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $2,281,476 | 11,187 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,672,724 | 12,691 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,116,080 | 12,988 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,862,530 | 13,649 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,499,086 | 12,993 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $7,154,046 | 25,573 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $6,305,144 | 25,750 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $7,470,144 | 26,333 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $6,872,824 | 25,688 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $8,311,302 | 26,270 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||